EUVIMEDEUVIMED entdecken
Crossref

An increased prevalence of carbapenem-resistant hypervirulent Klebsiella pneumoniae associated with the COVID-19 pandemic

Chao Liu, Jun Guo, Shuaihua Fan, Wei Guo, Huaiqing Qi, Stephen Baker, Pengcheng Du, Bin Cao

Drug Resistance Updates · 2024-11 · 77 · 101124

DOI: 10.1016/j.drup.2024.101124 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Resistance Updates, 2024-11. Verfasst von Chao Liu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Disease, Peking University Third Hospital, Beijing, China. Hauptthemen laut MEDLINE: COVID-19, Klebsiella pneumoniae, Klebsiella Infections, Carbapenems. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 48 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Peking University, Support Program for Longyuan Youth and Fundamental Research Funds for the Universities of Gansu Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Klebsiella pneumoniaeKlebsiella InfectionsCarbapenemsSARS-CoV-2Anti-Bacterial AgentsHumansPrevalenceVirulencePlasmidsPhylogenyPandemicsbeta-LactamasesBacterial ProteinsCarbapenem-Resistant EnterobacteriaceaeMicrobial Sensitivity Tests

Stichwörter der Autor:innen

COVID-19Klebsiella pneumoniaeWhole genome sequencecarbapenem-resistanthypervirulent

Substanzen

CarbapenemsAnti-Bacterial Agentsbeta-LactamasesBacterial Proteins

Autor:innen und Institutionen

  • Department of Infectious Disease, Peking University Third Hospital, Beijing, China.
  • Department of Pulmonary and Critical Care Medicine, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua University, Beijing, China.
  • Department of Medicine, University of Cambridge School of Clinical Medicine, Cambridge Biomedical Campus, Cambridge, United Kingdom.
  • Qitan Technology Ltd., Chengdu, China. Electronic address: dupengcheng126@126.com.
  • Department of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, National Clinical Research Center for Respiratory Diseases, China-Japan Friendship Hospital, Beijing, China; Department of Respiratory…

Förderung

  • National Natural Science Foundation of China
  • Peking University
  • Support Program for Longyuan Youth and Fundamental Research Funds for the Universities of Gansu Province
  • Zhejiang Provincial Program for the Cultivation of High-Level Innovative Health Talents
  • National Aerospace Science Foundation of China
  • State Key Laboratory of Nuclear Physics and Technology, Peking University
  • Beijing Municipal Education Commission

Zitieren

APA

Liu, C., Guo, J., Fan, S., Guo, W., Qi, H., Baker, S., Du, P., & Cao, B. (2024). An increased prevalence of carbapenem-resistant hypervirulent Klebsiella pneumoniae associated with the COVID-19 pandemic. Drug Resistance Updates, 77, 101124. https://doi.org/10.1016/j.drup.2024.101124

Vancouver

Liu C, Guo J, Fan S, Guo W, Qi H, Baker S, et al. An increased prevalence of carbapenem-resistant hypervirulent Klebsiella pneumoniae associated with the COVID-19 pandemic. Drug Resistance Updates. 2024;77:101124. doi:10.1016/j.drup.2024.101124

BibTeX
@article{Liu2024,
  author = {Liu, Chao and Guo, Jun and Fan, Shuaihua and Guo, Wei and Qi, Huaiqing and Baker, Stephen and Du, Pengcheng and Cao, Bin},
  title = {An increased prevalence of carbapenem-resistant hypervirulent Klebsiella pneumoniae associated with the COVID-19 pandemic},
  journal = {Drug Resistance Updates},
  year = {2024},
  volume = {77},
  pages = {101124},
  doi = {10.1016/j.drup.2024.101124}
}
Kostenlos starten →